Document is current

Any future updates will be listed below

Infarct-Limiting Efficacy of the μ2‑Opioid Receptor Peptide Agonist Endomorphin‑1 in Metabolic Syndrome and Aging

Crossref DOI link: https://doi.org/10.1007/s10517-026-06681-2

Published Online: 2026-06-02

Published Print: 2026-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark